CA2060208A1 - Traitement des plaies - Google Patents

Traitement des plaies

Info

Publication number
CA2060208A1
CA2060208A1 CA2060208A CA2060208A CA2060208A1 CA 2060208 A1 CA2060208 A1 CA 2060208A1 CA 2060208 A CA2060208 A CA 2060208A CA 2060208 A CA2060208 A CA 2060208A CA 2060208 A1 CA2060208 A1 CA 2060208A1
Authority
CA
Canada
Prior art keywords
wound healing
mammal
growth factor
healing
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2060208A
Other languages
English (en)
Other versions
CA2060208C (fr
Inventor
Harry N. Antoniades
Samuel E. Lynch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomimetic Therapeutics LLC
Harvard University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2060208A1 publication Critical patent/CA2060208A1/fr
Application granted granted Critical
Publication of CA2060208C publication Critical patent/CA2060208C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Electronic Switches (AREA)
CA002060208A 1990-04-10 1990-04-10 Traitement des plaies Expired - Lifetime CA2060208C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1990/001936 WO1991015231A1 (fr) 1990-04-10 1990-04-10 Cicatrisation de plaies

Publications (2)

Publication Number Publication Date
CA2060208A1 true CA2060208A1 (fr) 1991-10-11
CA2060208C CA2060208C (fr) 2001-02-20

Family

ID=22220789

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002060208A Expired - Lifetime CA2060208C (fr) 1990-04-10 1990-04-10 Traitement des plaies

Country Status (8)

Country Link
EP (1) EP0479799B1 (fr)
JP (1) JPH0768139B2 (fr)
AT (1) ATE156363T1 (fr)
CA (1) CA2060208C (fr)
DE (1) DE69031218T2 (fr)
DK (1) DK0479799T3 (fr)
ES (1) ES2106031T3 (fr)
WO (1) WO1991015231A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT948538E (pt) 1996-12-13 2008-08-05 Novartis Vaccines & Diagnostic Análise e separação de proteínas do factor de crescimento derivado de plaquetas
RU2149644C1 (ru) * 1997-11-28 2000-05-27 Открытое акционерное общество "СПб-Технология" Способ лечения заболеваний, сопровождающихся образованием гноя и/или некротических тканей
GB2369572A (en) 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
AUPR774201A0 (en) 2001-09-18 2001-10-11 U.S. Filter Wastewater Group, Inc. High solids module
US7247238B2 (en) 2002-02-12 2007-07-24 Siemens Water Technologies Corp. Poly(ethylene chlorotrifluoroethylene) membranes
CN101426565B (zh) 2004-04-22 2012-04-18 西门子工业公司 包含膜生物反应器和消化有机物质的处理容器的过滤装置
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
US7799754B2 (en) 2004-10-14 2010-09-21 Biomimetic Therapeutics, Inc. Compositions and methods for treating bone
US7591950B2 (en) 2004-11-02 2009-09-22 Siemens Water Technologies Corp. Submerged cross-flow filtration
CN101287538B (zh) 2005-08-22 2013-03-06 西门子工业公司 使用歧管以减少回洗的水过滤装置
WO2007044345A2 (fr) 2005-10-05 2007-04-19 Siemens Water Technologies Corp. Procede et appareil permettant de traiter des eaux usees
EP2431060B1 (fr) 2005-11-17 2020-04-08 BioMimetic Therapeutics, LLC Augmentation d'os maxillo-facial utilisant RHPDGF-BB et matrice biocompatible
US7455765B2 (en) 2006-01-25 2008-11-25 Siemens Water Technologies Corp. Wastewater treatment system and method
ES2664229T3 (es) 2006-06-30 2018-04-18 Biomimetic Therapeutics, Llc Composiciones y métodos de biomatriz-PDGF para el tratamiento de lesiones del manguito rotador
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
JP5552315B2 (ja) 2006-11-03 2014-07-16 バイオミメティック セラピューティクス， エルエルシー アースロデティック術のための組成物および方法
WO2009100454A1 (fr) 2008-02-07 2009-08-13 Biomimetic Therapeutics, Inc. Compositions et procédés associés à une ostéogenèse par distraction
NZ602861A (en) 2008-09-09 2014-03-28 Biomimetic Therapeutics Llc Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
CA2790403C (fr) 2010-02-22 2019-08-27 Biomimetic Therapeutics, Inc. Compositions de facteur de croissance derive des plaquettes et procedes pour le traitement de tendinopathies
CA2962954A1 (fr) 2014-10-14 2016-04-21 Samuel Lynch Compositions pour le traitement de plaies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960005708B1 (ko) * 1986-11-14 1996-05-01 인스티튜트 오브 몰레큘러 바이올로지, 인코오포레이티드 외상 치료 및 뼈 재생용 조성물
CA1322714C (fr) * 1986-11-14 1993-10-05 Harry N. Antoniades Cicatrisation et regeneration osseuse
US4885163A (en) * 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing

Also Published As

Publication number Publication date
EP0479799A1 (fr) 1992-04-15
JPH05500356A (ja) 1993-01-28
WO1991015231A1 (fr) 1991-10-17
DE69031218T2 (de) 1997-12-11
DK0479799T3 (da) 1997-08-25
ES2106031T3 (es) 1997-11-01
DE69031218D1 (de) 1997-09-11
EP0479799A4 (en) 1993-03-31
ATE156363T1 (de) 1997-08-15
CA2060208C (fr) 2001-02-20
EP0479799B1 (fr) 1997-08-06
JPH0768139B2 (ja) 1995-07-26

Similar Documents

Publication Publication Date Title
ZA878566B (en) Wound healing and bone regeneration
CA2040410A1 (fr) Compositions pour traiter des plaies contenant de l'interleukine 1 et un facteur de croissance
AU642784B2 (en) External dermatological composition
DE69031218D1 (de) Wundheilung
AU7191487A (en) Wound healing composition
AU4319789A (en) Wound healing
CS141387A2 (en) Microbicide
AU1871988A (en) Microbicide composition
AU2470288A (en) Acid gas absorbent composition
AU4302993A (en) 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxy lic acid compounds and related compounds as antibacterial agents
EP0440809A4 (en) Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient
AU1271592A (en) Malic acid derivatives and compositions for the treatment of psoriasis
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
CA2011452A1 (fr) Compose pharmaceutique contenant un vecteur acceptable en pharmacologie et un compose de (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-19-pregn-5-(10)-en-20-yn- 3-one
CA2058597A1 (fr) Compositions cicatrisantes a base de facteur de croissance de fibroblaste et d'acide ascorbique
AU2256888A (en) Wound dressings
CA2082420A1 (fr) Composition cicatrisante comprenant du igf-i ou igf-ii purifie et un tgf-.beta. purifie
AU1655388A (en) Pharmaceutical composition comprising a compound containing sulfhydryl group(s) for the treatment of otitis
GB2263234B (en) Composition for accelerating wound healing
AU4553189A (en) Fabric treatment composition
AU8372591A (en) Forage composition
AU7508594A (en) Medical use of polysulfonic acid compound
AU2403592A (en) 2-aza-2-desamino analogues of 5,8-dideazafolic acid
AU638339B2 (en) Auxiliary artificial heart of the embedded-in-body type
AU8282987A (en) Composition for defoliation of plants i

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry